Meningitis vaccinations for all college students? No
SPECIAL TO THE DENVER POST
[NOTE: This editorial is written by Robert F. Kennedy, Jr., but strangely, his name does not appear on the byline at the Denver Post’s website.]
With billions of dollars in annual revenue at stake, vaccine-makers are pushing meningitis vaccine mandates across the country. Vaccine issues are always complex, but advocates of the meningitis mandate should consider some simple math.
Meningococcal meningitis is exceedingly rare. There were only about 386 cases in the U.S. last year. In a population of 319 million, that adds up to one case in 817,949 people.
Of those who contract meningococcal disease, 10 to 15 percent die.
The CDC has approved three vaccines targeting the A, C, Y and W135 strains of meningitis: Menactra, Menveo and Menomune, which still contains significant mercury concentrations in multi-dose vials. These vaccines are effective in providing immunity to those strains of meningitis in only 85 percent of people who receive them.
There is no question that meningococcal meningitis is a serious disease that can cause death and disability, but we need to ensure that the solution is not worse than the problem.
There is every reason to believe that mandatory meningococcal B vaccines for every college student could kill more students than the disease they protect against. Before we relinquish our rights, pay millions and sicken students, we should do the math.
READ ENTIRE EDITORIAL HERE: http://www.denverpost.com/2015/06/19/meningitis-vaccinations-for-all-college-students-no/